Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

HEALTHCARE (NY: XLV )

136.88 -2.07 (-1.49%)
Streaming Delayed Price Updated: 10:43 AM EST, Dec 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about HEALTHCARE

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
S&P 500 rockets to new highs as earnings beat estimates
The S&P 500 hits new highs as 10 of the 11 S&P sectors report positive Q4 earnings surprises. The tech and energy sectors are among the earnings leaders. 
Via MarketBeat
Topics ETFs Earnings Stocks
Exposures Financial US Equities
Can financial, healthcare, energy stocks rise as rates stay high?
Sectors including financials, healthcare, utilities and energy outperform as interest rates remain high, but some of those industries face challenges in 2024. 
Via MarketBeat
3 Sector ETFs & Stocks To Bet On Superb January Jobs Data
In this article, we have highlighted some of the sectors that will likely see smooth trading in the days ahead in light of the January jobs data 
Via Talk Markets
Topics ETFs
XLV Making Strong Reaction Higher From Extreme Area
In this article, we will look at the past performance of the 4-hour Elliott Wave Charts of XLV 
Via Talk Markets
Forget Rate Cuts, Buy Top-Ranked Sector ETFs
Uncertainty surrounding the timing of rate cuts has been playing foul on the stock market this year. 
Via Talk Markets
Healthcare And Life Science Funds And ETFs Performance 2023-2024
Healthcare stocks usually provide a defensive posture to a stock portfolio. 
Via Talk Markets
Topics ETFs
Markets suddenly price Eli Lilly stock for a breakout on earnings
The healthcare sector could see a sudden inflow of investment dollars, and Eli Lilly quickly becomes a favorite name in the space as markets and analysts bid up 
Via MarketBeat
Topics Bonds Economy
Exposures Debt Markets Interest Rates
US Stocks Rise At Week's Start, Tesla Rebounds, SoFi, Lucid Shine: What's Driving Markets Monday?
Wall Street witnessed slight gains at midday on Monday, with investors eagerly awaiting a series of critical earnings reports, the Federal Reserve’s meeting on Wednesday and the much-anticipated job... 
Via Benzinga
Pfizer’s earnings growth trade at a deep discount, suddenly a buy
The healthcare sector is set to attract a new inflow of investment dollars, as seen in business activity and employment. Pfizer is the clear sector favorite 
Via MarketBeat
Topics Economy
Exposures Economy
Just What Powers The SPY
The S&P 500 closed the week below fresh highs thanks to a bout in tech and relative weakness in some semiconductors. The rally is broadening, though, with XLI and XLV appearing to be well-positioned. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Stocks Ease Despite Benign Inflation Data, Bitcoin Stages Comeback: What's Driving Markets Friday?
Stocks mixed in New York, with investors assessing mild inflation report and strong personal spending figures. Short-term Treasury yields rise, tech stocks lag, and Bitcoin surges 4.9%. Intel stock... 
Via Benzinga
Topics Economy
Exposures Interest Rates
5 top healthcare stocks for earnings growth in 2024
2024 holds promise for healthcare stocks, with Humana, Elevance, and others expected to boost earnings, as analysts say many industry pressures have been removed. 
Via MarketBeat
Baby Bust: Will Falling Global Birth Rates Drive Markets Lower?
In the U.S., the birth rate is still growing, but at a much slower rate since the global financial crisis in 2008. 
Via Benzinga
Weekly Market Pulse: Is The Recession Finally Here?
You need to sell when things look great – but not too soon – and buy when things look awful – but not too soon. 
Via Talk Markets
Topics Economy
Exposures Economy
Pfizer, Autodesk, AbbVie And More: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Liz Young of BNY Mellon Investment Management named Health Care Select Sector SPDR Fund (NYSE: XLV) 
Via Benzinga
Did Today's Volume Signal New Record Highs Ahead Of Sentiment
An analysis of the major indexes' movement on higher than average volume. 
Via Talk Markets
AI Drives Tech Rebound, Oil Soars, Bitcoin Tumbles: What's Driving Markets Thursday?
During midday Thursday trading in New York, U.S. stocks displayed mixed performance, with the technology sector outperforming others as investors maintained a bullish outlook on artificial... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Healthcare Sector Is Off To A Strong, Market-Leading Start In 2024
After a modest loss in 2023, shares in the healthcare sector are enjoying a market-leading rebound so far in the new year. 
Via Talk Markets
US Stocks Sink, Tech And Real Estate Hit Hard Amid Rate Concerns, Dollar Surge: What's Driving Markets Wednesday?
Another day of losses shook up Wednesday’s stock trading session on Wall Street. All major U.S. stock indices in the red, as investors expressed concerns that the Federal Reserve is not in a rush to... 
Via Benzinga
Topics Economy
Exposures Interest Rates
Are CVS store closures prescription for better financial health?
CVS plans to close dozens of Target pharmacies starting in February. Amid retail pharmacy challenges, CVS is shifting toward the managed-care industry. 
Via MarketBeat
Topics Economy
Exposures Interest Rates
UnitedHealth's rising premiums could cushion stubborn inflation
The healthcare sector is one of the prime suspects to attract safety-seeking investors in the coming market shift. Within it, THIS stock can prove a winner 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
2023 Year-End Sector Review – Part 2
In this 2023 year-end sector review, we will take a look at what kind of year it was for healthcare, industrial, technology, materials, REITs, and utility sectors. Additionally, how is 2024 shaping up... 
Via Talk Markets
AstraZeneca: Rebound in 2024 with double-digit earnings growth
AstraZeneca's stock rose 8.95% in the past month on a bullish outlook, driven by growing sales of cancer and diabetes drugs and a strategic acquisition 
Via MarketBeat
Exposures COVID-19
S&P 500's Projected EPS Growth In 2024: Why QQQ, QQQM Might Lead The Way
The S&P 500 is poised to deliver double-digit growth to investors in 2024, fueled by 3 sectors. Even then, the Nasdaq-100 could outpace S&P 500. Here's why. 
Via Benzinga
Topics Stocks
Exposures US Equities
HCA Healthcare Rallies: Weight-loss drugs really a big threat?
HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges. 
Via MarketBeat
Topics ETFs
Are defensive sectors ready to outshine growth in 2024?
Is 2024 the year defensive stocks rotate into leadership? As the year gets underway, defensives such as healthcare, energy, utilities and consumer staples lead. 
Via MarketBeat
Charted: S&P 500 Sector Performance In 2023
Information Technology, Communication Services, and Consumer Discretionary were the three biggest winners in 2023, all of them up more than 40% for the year. 
Via Talk Markets
Topics Stocks
Exposures US Equities
US Stocks Eye 3-Day Slump; Tech, Crypto Sell-Off Deepens, Oil, Dollar Rebound: What's Driving Markets Wednesday?
The early 2024 sell-off is intensifying on Wall Street, with all major stock averages in the red on the second trading day of 2024. 
Via Benzinga
Did Santa Claus Claus Leave Town A Day Early?
With the exception of the Dow, stocks are down hard to begin the new calendar year. 
Via Talk Markets
Topics Stocks
Exposures US Equities
3 Biotech Stocks Set for Breakthroughs in 2024
With groundbreaking advancements in new medicine and science, 2024 holds a promising future for these biotech stocks. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.